D

Delcath Systems
D

DCTH

16.160
USD
0.92
(6.04%)
مغلق
حجم التداول
16,470
الربح لكل سهم
-0
العائد الربحي
-
P/E
-14
حجم السوق
584,992,000
أصول ذات صلة
الأخبار المقالات

العنوان: Delcath Systems

القطاع: Healthcare
الصناعة: Medical Devices
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS,is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.